Canal Biosciences
Canal Biosciences Inc. is a privately held genomics-tools company that sells end-repair-free DNA library preparation kits based on its patented TrueLink® enzyme platform, serving research institutions conducting NGS workflows in liquid biopsy and methylation analysis.
- Company typePrivate
- Founded2024
- HeadquartersLowell, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Canal Biosciences does
Canal Biosciences Inc. is a privately held precision-medicine and genomics-tools company that develops and sells DNA library preparation kits for next-generation sequencing (NGS). Its core platform, TrueLink®, uses proprietary enzymes and adaptors in a simultaneous dual-ligation workflow that attaches sequencing adaptors directly to native DNA termini, eliminating the conventional end-repair and A-tailing steps that the company says introduce artifacts, destroy native terminal structure, and obscure methylation signals. The technology is protected by U.S. Patent No. US 12,644,146 and is offered in 24-reaction (TL0001-24) and 96-reaction (TL0001-96) kit formats, supported by the DISTAL-seq and DISTAL-methyl-seq application workflows aimed at liquid biopsy, MRD detection, and methylation analysis.
The company targets research institutions running advanced NGS workflows, particularly in liquid biopsy and cancer-detection applications where preservation of native DNA terminal structure is critical. All products are labeled for Research Use Only (RUO), and Canal sells direct to customers via phone and email on a quote-based pricing model, with custom formulations available on request. Canal Biosciences was founded in 2024, operates from the UMass Lowell M2D2 incubator at 110 Canal Street, Lowell, MA, and is led by Founder & Co-CEO YuZheng alongside Co-CEO Chris Benoit, CFO Jack Percoskie, VP of R&D Matt Hims, and Development Scientist Gary Teeters. The company is privately held with no disclosed institutional investors, no named customers, no partnerships, and no disclosed revenue; a ~$2.33M funding round closed on 2026-04-13 with undisclosed investors.
Canal Biosciences firmographics
Firmographics- Name
- Canal Biosciences
- Legal name
- Canal Biosciences Inc.
- Website
- https://canalbiosciences.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Canal Biosciences Inc. is a privately held genomics-tools company that sells end-repair-free DNA library preparation kits based on its patented TrueLink® enzyme platform, serving research institutions conducting NGS workflows in liquid biopsy and methylation analysis.
- Ownership category
- akta.pro rank
Canal Biosciences industry classification
Industry- Product category
- Genomics Reagents and Kits
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industries
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)
Keywords
Where Canal Biosciences is headquartered
LocationHeadquarters
- HQ city
- Lowell
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Canal Biosciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Research Use Products: Sale of DNA library preparation kits and reagents for research use only. Products include TrueLink® DNA Library Prep Kit-24 (TL0001-24) and TrueLink® DNA Library Prep Kit-96 (TL0001-96). Custom products available through quotes based on product specifications.
- Custom Product Quotes: Custom products and specialized formulations available through quote-based pricing mechanism.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | TrueLink® DNA Library Prep Kit-24 (TL0001-24) |
| Unit Pricing | Pay-as-you-go | TrueLink® DNA Library Prep Kit-96 (TL0001-96) |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Canal Biosciences product offering
Product offeringCore offering
Canal Biosciences develops and sells DNA library preparation kits for next-generation sequencing (NGS), built on its proprietary TrueLink® platform. The kits use a simultaneous dual-ligation workflow with proprietary enzymes and adaptors to attach sequencing adaptors directly to native DNA termini without end repair, preserving native DNA structure and reducing sequencing costs. Specialized applications include DISTAL-seq and DISTAL-methyl-seq for liquid biopsy and methylation analysis.
Product overview
Canal Biosciences offers a unified product platform centered on TrueLink® technology — an end-repair-free NGS library preparation system. The core products are the TrueLink® DNA Library Prep Kits (available in 24-reaction and 96-reaction formats), which employ proprietary enzymes and adaptors in a simultaneous dual-ligation workflow. Supporting the kit platform are specialized assay applications: DISTAL-seq and DISTAL-methyl-seq, which are enabled by TrueLink®'s ability to preserve native DNA terminal structure for liquid biopsy, MRD detection, and methylation sequencing applications. The company also offers Custom Products for customers with specific manufacturing requirements.
Differentiator
Problem solved
Functional benefit
Brands
- TrueLink®: Proprietary end-repair-free NGS library preparation technology that preserves native DNA structure.
- DISTAL-seq
- DISTAL-methyl-seq
Products and services
- TrueLink® DNA Library Prep Kit-24 NGS library preparation kit with 24 reactions, using TrueLink® end-repair-free technology that preserves native DNA structure by attaching sequencing adaptors directly to native termini without writing, erasing, or using splints. Sold for Research Use Only to research institutions.
- TrueLink® DNA Library Prep Kit-96 NGS library preparation kit with 96 reactions, using TrueLink® end-repair-free technology that preserves native DNA structure by attaching sequencing adaptors directly to native termini without writing, erasing, or using splints. Sold for Research Use Only to research institutions.
- DISTAL-seq An NGS assay application enabled by TrueLink® technology, designed for liquid biopsy and methylation sequencing applications where preserving fragment termini is critical for clinical sequencing reliability and minimal residual disease (MRD) detection.
- DISTAL-methyl-seq A methylation sequencing application utilizing TrueLink® technology, designed for methylation analysis where end repair and A-tailing steps in conventional library prep obscure methylation at fragment termini.
Quantifiable outcome
- Reduces sequencing costs by safeguarding every DNA molecule
Companies that use Canal Biosciences
Customer profileSegments1 record
Ideal customer profiles1 record
Canal Biosciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Canal Biosciences partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Canal Biosciences competitors and assessment
Company assessmentDirect peers
- Agilent Technologies: Agilent's SureSelect and related library prep chemistries are staples of exome and targeted sequencing workflows, competing directly for research lab reagent budgets.
- Twist Bioscience: Twist sells NGS library prep and target enrichment products, competing in the same consumables market where Canal's TrueLink® kits are sold.
- New England Biolabs (NEB): NEB sells the NEBNext® family of NGS library prep kits and reagents, directly competing with Canal's TrueLink® kits for DNA library preparation market share in research labs.
- 10x Genomics: 10x Genomics sells single-cell and spatial library prep kits; while the chemistry differs, the company competes for NGS consumables spend in the same advanced genomics research market.
- Qiagen: Qiagen's QIAseq library prep kits and sample-prep reagents overlap with Canal's product offering for NGS sample preparation in research and translational labs.
- Integrated DNA Technologies (IDT, Danaher): IDT's xGen™ library prep and adaptors are widely adopted NGS reagents, making it a direct competitor in the same end-repair-and-ligation workflow Canal seeks to disrupt.
- Roche (KAPA Biosystems): Roche's KAPA portfolio (e.g., KAPA HyperPrep) is a leading library prep brand used in research and clinical NGS, competing head-to-head with TrueLink® for both reagents and OEM supply.
Broad incumbents
- Illumina: Illumina dominates sequencing and also sells library prep reagents (e.g., DNA Prep), serving as a broad incumbent across the NGS workflow Canal is targeting.
- Element Biosciences: Element sells sequencing instruments and配套 library prep chemistry; as an emerging sequencing platform vendor it competes for the broader NGS consumables and workflows Canal addresses.
- Pacific Biosciences: PacBio offers long-read sequencing platforms with associated library prep reagents, representing a broader incumbent in NGS where Canal's TrueLink® could be positioned as a complementary workflow.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights5 records
Customer concentration
Canal Biosciences social profiles
Digital presenceCanal Biosciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Canal Biosciences leadership team
Management profileNumber of profiles
Profiles5 records
Canal Biosciences funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Canal Biosciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Canal Biosciences
What does Canal Biosciences do?
Canal Biosciences develops and sells DNA library preparation kits for next-generation sequencing (NGS), built on its proprietary TrueLink® platform. The kits use a simultaneous dual-ligation workflow with proprietary enzymes and adaptors to attach sequencing adaptors directly to native DNA termini without end repair, preserving native DNA structure and reducing sequencing costs. Specialized applications include DISTAL-seq and DISTAL-methyl-seq for liquid biopsy and methylation analysis.
Is Canal Biosciences a public or private company?
Canal Biosciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Canal Biosciences founded?
Canal Biosciences was founded in 2024. It employs 1 to 10 people.
Where is Canal Biosciences based?
Canal Biosciences is headquartered in Lowell, United States, in the North America region.
How does Canal Biosciences make money?
Two revenue lines are on record. Research Use Products are the primary driver. The others are custom Product Quotes.
Who are Canal Biosciences's main competitors?
Direct peers on record are Agilent Technologies, Twist Bioscience, New England Biolabs (NEB), 10x Genomics, Qiagen, Integrated DNA Technologies (IDT, Danaher) and Roche (KAPA Biosystems). Broad incumbents are Illumina, Element Biosciences and Pacific Biosciences.
Does Canal Biosciences have an API?
No public API is recorded for Canal Biosciences.
What industry is Canal Biosciences in?
Canal Biosciences's product category is Genomics Reagents and Kits. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services. Its NAICS code is 334516 and its SIC code is 3826.